Trinity Biotech plc
TRIB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | – | – | – | – |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | – | – | – |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 8.3% | -9.1% | -23% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 34.8% | 34.2% | 35.3% | 41.2% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -27.5% | -42.4% | -26.7% | 13.1% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -51.6% | -42.3% | -65.6% | 1.1% |
| EPS Diluted | -1.77 | -3.2 | -5.2 | 0.16 |
| % Growth | 44.7% | 38.5% | -3,350% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |